Filing Flows › Zomedica (ZOMDF) › Q1 2025
Zomedica (ZOMDF) Q1 2025 earnings results (first quarter 2025)
10-Q filed May 15, 2025
Zomedica (ZOMDF) reported revenue of $6.5M for the first quarter 2025 (Q1 2025), +4% from a year earlier and -18% from the quarter before. Operating margin was -993.0%, net loss $63.8M (981.7% of revenue).
Zomedica, Q1 2025: revenue $6.5M (+4% year over year), operating margin -993.0%, net loss $63.8M, operating cash flow −$6.6M. The chart follows the revenue to costs, profit and cash.
| Q1 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $6.5M | -18% | +4% |
| Operating profit | −$64.5M | — | — |
| Net earnings | −$63.8M | — | — |
| Operating cash flow | −$6.6M | — | — |
What changed
Revenue was $6.5M in Q1 2025, up 4% year over year and down 18% from the previous quarter. Consumables was the largest line at 69% of revenue. Consumables added $487K year over year (up 12%), 205% of the total change. Capital declined 12%.
Gross margin was 67.8%, up 2.1 points from a year earlier. Operating costs exceeded revenue by $64.5M, an operating margin of -993.0%. Operating expenses grew 375% against revenue growth of 4%. The fastest-growing cost line was Sales & marketing (+22%). The quarter ended with a net loss of $63.8M, wider than the previous quarter's $7.2M loss.
Operating cash flow was −$6.6M. Non-cash charges added back $2.2M of depreciation and amortization and $618K of share-based compensation. Working capital and other items added $54.3M. Capital expenditures of $280K exceeded it, leaving free cash flow of −$6.9M.
Questions
What was Zomedica's revenue in the first quarter 2025?
Zomedica (ZOMDF) reported revenue of $6.5M for the first quarter 2025 (Q1 2025), +4% from a year earlier and -18% from the quarter before.
Was Zomedica profitable in the first quarter 2025?
Operating loss was $64.5M (-993.0% of revenue) and net loss $63.8M.
Source: Zomedica 10-Q on SEC EDGAR.